If youre a clinician considering microdosing: Be explicit: We dont know exactly how or why this might work at this dose Consider it especially for: Normal-weight patients with metabolic dysfunction Patients who cant tolerate higher doses Conditions with strong mechanistic rationale (PCOS, autoimmune disease, addiction) Monitor objectively: weight and body composition, waist circumference, labs, symptom scores, not just subjective reports Track patients who dont lose weight but report benefits - these are your most interesting cases Document everything, contribute to registries If youre a patient considering microdosing: Understand that benefits without weight loss are reported but not proven Know that you might be benefiting from small amounts of visceral fat loss that dont show on your scale Be skeptical of your own subjective improvement (placebo is real) Know that all medications come with possible side effects Work with a clinician who will help you figure out if its actually working If youre a researcher: Please study the minimal effective dose Use imaging to measure visceral fat, not just scale weight Design studies in normal-weight metabolically unhealthy individuals Compare weight-matched groups to isolate non-weight-loss effects My opinion

Monitoring and Maintenance Regardless of the rating, consistent monitoring helps prolong battery life
5 Mechanisms of tamoxifen-induced apoptosis Apoptosis plays a vital role in the modulation of neoplastic transformation of cells
Figure 4: Serum IGF-1 levels in different experimental groups In addition to changes in serum levels, both KID and KIR mice saw significant increases in body weight from 4 to 16 weeks in age
The Pharmacy Compounding Advisory Committee provides advice to the FDA
This powerful yet non-harmful chemical peel can rejuvenate your aging or sun-damaged skin